RAD23A

Across TCGA pan-cancer cohorts, RAD23A RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RAD23A’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RAD23A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RAD23A is over-expressed in tumor.

KIRC, HNSC, and KIRP are the cancer types where RAD23A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RAD23A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.901	<.001	12	view →
HNSC	All	III,IV	+0.761	<.001	12	view →
KIRP	Female	II,III,IV	+1.048	<.001	11	view →
COAD	Male	IV	+0.903	<.001	11	view →
LIHC	All	III,IV	+0.762	<.001	9	view →
LUSC	Male	II,III,IV	+0.702	<.001	7	view →
STAD	Male	II,III,IV	+0.949	<.001	6	view →
CHOL	All	All	+1.516	<.001	5	view →
BLCA	Female	All	+0.535	.006	5	view →
READ	All	All	+0.477	<.001	5	view →
BRCA	All	All	+0.154	.016	4	view →
ESCA	All	All	+1.039	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RAD23A–KIRC

Open the KIRC breakdown →